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Letters
RESEARCH LETTER
Use of anOnline Crowdfunding Platform for
Unmet Financial Obligations in Cancer Care
Technologic innovations, expensive new therapies, and im-
proved access to treatment have all contributed to the rising
costs of oncologic care in theUnitedStates.1 The financial con-
sequences for patients and their families are substantial. Pa-
tients with cancer often borrow money, avoid leisure activi-
ties, decrease food spending, sell possessions, go into debt,
and/ordeclarebankruptcy,2 and theyare at greater risk fordis-
ability or unemployment.3 These consequences are particu-
larly great forpatientswhoareunderinsuredoruninsured.Re-
cently, online crowdfunding platforms are being increasingly
used to supplement insurance and defray expenses, even for
experimental and unproven treatments.4 We sought to char-
acterize the use of crowdfunding to support oncology care
needs, includinganyassociationbetween insurancestatusand
other characteristics.
Methods |We identified the top 20 most prevalent cancers in
the United States using data from the National Cancer Insti-
tute. Each cancer andUS statewas queried on theGoFundMe
platform (www.gofundme.com) for 1000 individual searches
(50 states × 20 top cancers = 1000batches of searches). Using
custom code for web scraping (software used to abstract and
assemblewebsitedata foranalysis),we identified37344cancer
campaigns onOctober 7, 2018.Weuseda randomizer to select
1035 campaigns,whichwe studied indetail. Narratives report
details regarding apatient’s oncologic treatment andpersonal
and financial life. We selected variables of interest using a
roundtable discussion among all authors and 2 rounds of
iterative testing to ensure consensus and reproducibility in
extracting data. We determined insurance status from
campaignauthor self-reporting anddefined theunderinsured
as thosewhostated that theywereunderinsuredoruninsured.
The institutional review board at the University of California,
SanFranciscodeemed this studyexemptbecauseall datawere
publicly available.
Interrater reliability for collected clinical and financial de-
tails exceeded κ > 0.81. Descriptive statistics, χ2, Fisher ex-
act, and Kruskal-Wallis testing were used to compare charac-
teristics by insurance status as well as associations between
reported variables and donation totals using Stata 15 soft-
ware (StataCorp). P values < .05were considered statistically
significant.
Results | Campaigns commonly described details regarding
age, employment status, cancer type, treatment plans, and
prognosis (Table). The median fund-raising goal and dona-
tions obtained were $10 000 (interquartile range [IQR],
$5000-$20000) and $2125 [IQR, $860-$5475], respectively.
The most common campaign purposes were paying medical
bills (n = 424 of 1035 [41.0%]), medical travel (n = 262
[25.3%]) and nonmedical bills (n = 240 [23.2%]), with 18
(1.7%) posters mentioning alternative treatments (Figure).
Campaigns for underinsured patients requested $10 000
more on average than those that did not mention insurance.
Campaigns with underinsured patients made up 26.2%
(n = 271) of the population and were more likely to seek
funds for unpaid medical bills compared with those that did
not mention insurance (n = 178 of 271 [65.7%] vs n = 245 of
764 [32.1%], P < .01). Posters received approximately a quar-
ter of their requested goal, independent of insurance status
(Table). The underinsured, compared with those not men-
tioning insurance, reported unstable employment (n = 107
of 271 [39.8%] vs n = 214 of 764 [28.0%], P < .01) and were
more likely to mention prior surgical treatment (n = 105 of
271 [38.8%] vs n = 214 of 764 [28.0%], P < .01). There were
no significant differences in patient age, sex, type of cancer,
or insurance status with regard to donation totals.
Discussion | We have provided a detailed accounting of the
characteristics of patients using a crowdfunding platform to
support oncologic financial needs. The underinsured seek
but do not receive higher donation amounts. Although the
Affordable Care Act reduced the uninsured rate, cost con-
tainment measures have not been realized by all patients.5
In this cohort, patients reported multiple competing finan-
cial needs, but most pressing were unpaid medical bills,
which may represent copays, out-of-pocket drug costs, or
high deductibles. Medical travel costs also were highly
cited; we speculate that regionalization of oncologic care
may improve outcomes but increase the financial burden on
patients.6 Limitations of the present study include general-
izability to other patients, inability to determine the verac-
ity of online claims, and determination of insurance status
by narrative self-report. Nonetheless, these results suggest
that the financial burden of health care requires increasing
attention and advocacy.
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Table. Posted Cancer Specifics Stratified by Insurance Status
Characteristic
No. of
Campaigns (%)
(n = 1035)a
Campaigns
With No Mention
of Insurance,
No. (%)(n = 764)
Campaigns for
Underinsured/
Uninsured Patients,
No. (%) (n = 271) P Value
Demographic Characteristics
Female sex 578 (56.1) 429 (56.5) 149 (55.0) .75
Patient age group
Adult (≥18 y) 881 (85.1) 641 (83.9) 240 (88.6)
.09
Child (<18 y) 100 (9.7) 83 (10.9) 17 (6.3)
Clinical Characteristicsb
Cancer type
Breast 189 (18.3) 142 (18.6) 47 (17.3)
.61
Leukemia 135 (13.0) 105 (13.7) 30 (11.1)
Lung 113 (10.9) 82 (10.7) 31 (11.4)
Colon 72 (7.0) 51 (6.7) 21 (7.8)
Pancreatic 52 (5.0) 36 (4.7) 16 (5.9)
Brain 43 (4.2) 36 (4.7) 7 (2.6)
Liver 43 (4.2) 31 (4.1) 12 (4.4)
Bone 28 (2.7) 23 (3.0) 5 (1.9)
Otherc 360 (34.8) 258 (33.8) 102 (36.6)
Stage
I 15 (1.5) 9 (1.2) 6 (2.4)
.05II or III 102 (10.1) 65 (8.8) 37 (13.9)
IV or higher 320 (31.7) 236 (31.8) 84 (31.5)
Past treatment
Chemotherapy 434 (41.9) 314 (41.1) 120 (44.3) .36
Radiation 145 (14.0) 99 (13.0) 46 (17.0) .10
Surgery 319 (30.8) 214 (28.0) 105 (38.8) <.01
Future treatment
Chemotherapy 230 (22.2) 151 (19.8) 79 (29.2) <.01
Radiation 92 (8.9) 61 (8.0) 31 (11.4) .09
Surgery 121 (11.7) 75 (9.8) 46 (17.0) <.01
Immunotherapy 15 (1.5) 7 (0.9) 8 (3.0) .03
Alternative medicine 45 (4.4) 34 (4.5) 11 (4.1) .79
Family Characteristics
Loss of occupation 318 (31.0) 211 (28.0) 107 (39.8) <.01
Patient is primary wage earner 184 (18.0) 113 (15.0) 71 (26.4) <.01
Patient with child <18 y 155 (30.0) 106 (28.2) 49 (34.8) .08
Social Network Characteristics
Campaign author
Third party 342 (33.0) 257 (33.6) 85 (31.4)
.03
Unknown 149 (14.4) 120 (15.7) 29 (10.7)
Family other 156 (15.1) 119 (15.6) 37 (13.7)
Child 162 (15.7) 118 (15.5) 44 (16.2)
Self 134 (13.0) 84 (11.0) 50 (18.5)
Parent 49 (4.7) 36 (4.7) 13 (4.8)
Spouse 43 (4.2) 30 (3.9) 13 (4.8)
Online sharesd
Mean 366 376 338
.18
Median (IQR) 187 (84-408) 182 (74-394) 205 (98-438)
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Table. Posted Cancer Specifics Stratified by Insurance Status (continued)
Characteristic
No. of
Campaigns (%)
(n = 1035)a
Campaigns
With No Mention
of Insurance,
No. (%)(n = 764)
Campaigns for
Underinsured/
Uninsured Patients,
No. (%) (n = 271) P Value
Fund-raising, $
Goal
Mean 21 189 18 490 28 773
<.01
Median (IQR) 10 000 (5000-20 000) 10 000 (5000-20 000) 10 000 (6000-25 000)
Raised
Mean 5261 5197 5439
.20
Median (IQR) 2125 (860-5475) 2135 (872-5543) 2109 (800-5270)
Abbreviation: IQR, interquartile range.
a Column percentagemay not equal 100% owing to a lack of mention in online campaigns or in the case of past or future
treatment (multiple simultaneous treatments).
b Because the table reports mentions in online campaigns, absence does not necessarily equate with true absence of a
characteristic.
c Other includes bladder, cervical, kidney, melanoma, non-Hodgkin lymphoma, oral cancer, ovarian, prostate, rectal, skin,
stomach, thyroid, uterine, testicular, and rare cancers.
dNumber of campaign online social media shares as reported by the online crowdfunding platform.
Figure. Stated Purpose for Requested Funds on anOnline Crowdfunding Platform
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Dots represent overlapping reasons for seekingmoney on an online crowdfunding platform. Overlappingmentions of 3 or fewer are not shown. The top bar graph
provides the frequency of each combination, whereas the left bar graph summarizes totals.
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